Luc Morin

Luc Morin

Auto-generated profile, based on publicly available information

Luc Morin

Université Paris-Saclay, AP-HP, Service de réanimation pédiatrique et médecine néonatale, Hôpital de Bicêtre, Le Kremlin-Bicêtre, F-94275, France

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2016 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
EEEspnic Refractory Septic Shock Definition Taskforce The Infection Systemic Inflammation Sepsis Section Of Espnic
Espnic Refractory Septic Shock Definition Taskforce The Infection Systemic Inflammation Sepsis Section Of Espnic
LMLuc Morin
Luc Morin
SRSamiran Ray
Samiran Ray
CWClare Wilson
Clare Wilson
SRSolenn Remy
Solenn Remy
PTPierre Tissières
Pierre Tissières
Purpose Although overall paediatric septic shock mortality is decreasing, refractory septic shock (RSS) is still associated with high mortality. A definition for RSS is urgently needed to facilitate earlier identification and treatment. We aim to establish a European society of paediatric and neonatal intensive care (ESPNIC) experts’ definition of paediatric RSS. Methods We conducted a two-round Delphi study followed by an observational multicentre retrospective study. One hundred and fourteen paediatric intensivists answered a clinical case-based, two-round Delphi survey, identifying clinical items consistent with RSS. Multivariate analysis of these items in a development single-centre cohort (70 patients, 30 % mortality) facilitated development of RSS definitions based on either a bedside or computed severity score. Both scores were subsequently tested in a validation cohort (six centres, 424 patients, 11.6 % mortality). Results From the Delphi process, the draft definition included evidence of myocardial dysfunction and high blood lactate levels despite high vasopressor treatment. When assessed in the development population, each item was independently associated with the need for extracorporeal life support (ECLS) or death. Resultant bedside and computed septic shock scores had high discriminative power against the need for ECLS or death, with areas under the receiver operating characteristics curve of 0.920 (95 % CI 0.89–0.94), and 0.956 (95 % CI 0.93–0.97), respectively. RSS defined by a bedside score equal to or higher than 2 and a computed score equal to or higher than 3.5 was associated with a significant increase in mortality. Conclusions This ESPNIC definition of RSS accurately identifies children with the most severe form of septic shock.

14 October 2016 in European Heart Journal: Acute Cardiovascular Care
Verified
Journal Article
Closed access
PDF file
ABAlban Elouen Baruteau
Alban Elouen Baruteau
TBThomas Barnetche
Thomas Barnetche
LMLuc Morin
Luc Morin
ZJZakaria Jalal
Zakaria Jalal
NBNicholas S Boscamp
Nicholas S Boscamp
ATAlejandro J Torres
Alejandro J Torres
Background: Transcatheter techniques are emerging for left atrial (LA) decompression under venoarterial extracorporeal membrane oxygenation (VA-ECMO). We aimed to assess whether balloon atrioseptostomy (BAS) is a safe and efficient strategy. Methods: All patients who underwent percutaneous static BAS under VA-ECMO at four tertiary institutions were retrospectively reviewed. Results: From 2000 to 2014, BAS was performed in 64 patients (32 adults and 32 children). Indications for ECMO support included acute myocarditis (31.3%) and non-myocarditis cardiac disease, mostly end-stage dilated cardiomyopathy (32.8%). BAS was required because of pulmonary oedema/haemorrhage and left ventricular (LV) distension. The mean balloon diameter was 21.8 ± 8.4mm. Adequate LA decompression was achieved in all patients. Mean LA pressure fell from 24.2 ± 6.9 mmHg to 7.8 ± 2.6 mmHg (p < 0.001). The left-to-right atrial pressure gradient fell from 17.2 ± 7.1 mmHg to 0.09 ± 0.5 mmHg (p < 0.001). Echocardiography showed an unrestrictive left-to-right atrial shunting in all patients. Improvement of day 1 chest X-ray was observed in 76.6% of patients, clinical status in 98.4% of patients and pulmonary haemorrhage in 14 out of 14 patients. Complications occurred in 9.4% of patients, representing pericardial effusion, fast atrial fibrillation, ventricular fibrillation requiring defibrillation, transient complete heart block and femoral venous dissection requiring covered stent placement. In the 37 (57.8%) patients who were successfully decannulated, the median ECMO duration was 9 (range: 4–24) days. After a median follow-up of 12.3 (range: 0.1–142) months, 35.9% patients died, 17.2% received a LV assist device as a bridge to transplantation, 31.2% were transplanted and 56.2% were home discharged and alive. Conclusions: Percutaneous BAS may be a safe and efficient strategy for discharging the LA in both adults and children supported by VA-ECMO.

14 April 2022 in Pediatric Research
Verified
Journal Article
Closed access
PDF file
MCMelinda J. Cory
Melinda J. Cory
PDPhillippe Durand
Phillippe Durand
RSRafael Sillero
Rafael Sillero
LMLuc Morin
Luc Morin
RSRashmin C. Savani
Rashmin C. Savani
DADimitrios Angelis
Dimitrios Angelis

1 March 2020 in The Journal of Pediatrics
Verified
Journal Article
Closed access
LGLaetitia Giorgi
Laetitia Giorgi
PDPhillippe Durand
Phillippe Durand
LMLuc Morin
Luc Morin
JMJordi Miatello
Jordi Miatello
ZMZied Merchaoui
Zied Merchaoui
AOAugustin Ozanne
Augustin Ozanne

2 March 2021 in JACEP Open
Verified
Journal Article
Open access
PDF file
RCRamy C. Charbel
Ramy C. Charbel
VOVincent Ollier
Vincent Ollier
SJSebastien Julliand
Sebastien Julliand
GJGilles Jourdain
Gilles Jourdain
NLNoëlla Lode
Noëlla Lode
LMLuc Morin
Luc Morin
Study objective In prehospital and emergency settings, vasoactive medications may need to be started through a peripheral intravenous catheter. Fear of extravasation and skin injury, with norepinephrine specifically, may prevent or delay peripheral vasopressor initiation, though studies from adults suggest the actual risk is low. We sought to study the risk of extravasation and skin injury with peripheral administration of norepinephrine in children in the prehospital setting. Methods We performed a retrospective study of pediatric patients (≤18 years) who received a vasopressor during prehospital transport. We collected data from retrieval and hospital records from 2 pediatric medical retrieval teams in the Paris/Ile‐de‐France region. Patients were eligible if they had documentation of distributive or obstructive shock and administration of norepinephrine through a peripheral catheter (intravenous or intraosseous) during retrieval. The primary outcomes were the occurrence of extravasation and evidence of skin injury. We also examined approach to norepinephrine administration (concentration, duration, proximal vs distal site) and hospital outcomes. Results Over a 3‐year‐period, 37 pediatric patients received norepinephrine through a peripheral catheter (33 intravenous, 4 intraosseous). Median patient age was 1.8 years. Thirty‐two patients (86.5%) had septic shock. The median total duration of norepinephrine infusion was almost 4 hours. One patient (2.7%, 95% confidence interval 0.5%, 13.8%) had suspected extravasation from a 24‐gauge intravenous catheter in the hand, with local skin hypoperfusion. Skin changes were noted after 135 minutes of norepinephrine infusion. Perfusion normalized after catheter removal, and there were no other sequelae. Conclusions In a 3‐year sample of pediatric patients from a large metropolitan area, we found only 1 patient with evidence of any harm with peripheral administration of norepinephrine. This finding is consistent with the adult literature but requires multicenter and multiyear investigation before a firm recommendation for this practice can be made.

28 June 2019 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
LMLuc Morin
Luc Morin
MKMartin Kneyber
Martin Kneyber
NJNicolaas J. G. Jansen
Nicolaas J. G. Jansen
MPMark J. Peters
Mark J. Peters
EJEtienne Javouhey
Etienne Javouhey
PTPierre Tissières
Pierre Tissières
The Surviving Sepsis Campaign and the American College of Critical Care Medicine guidelines have provided recommendations for the management of pediatric septic shock patients. We conducted a survey among the European Society of Pediatric and Neonatal Intensive Care (ESPNIC) members to assess variations to these recommendations. A total of 114 pediatric intensive care physicians completed an electronic survey. The survey consisted of four standardized clinical cases exploring seven clinical scenarios. Among the seven different clinical scenarios, the types of fluids were preferentially non-synthetic colloids (albumin) and crystalloids (isotonic saline) and volume expansion was not limited to 60 ml/kg. Early intubation for mechanical ventilation was used by 70% of the participants. Norepinephrine was stated to be used in 94% of the PICU physicians surveyed, although dopamine or epinephrine is recommended as first-line vasopressors in pediatric septic shock. When norepinephrine was used, the addition of another inotrope was frequent. Specific drugs such as vasopressin or enoximone were used in < 20%. Extracorporeal life support was used or considered by 91% of the physicians audited in certain specific situations, whereas the use of high-flow hemofiltration was considered for 44%. This pediatric septic shock management survey outlined variability in the current clinician-reported practice of pediatric septic shock management. As most recommendations are not supported by evidence, these findings outline some limitation of existing pediatric guidelines in regard to context and patient’s specificity.